Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2
The Omicron strains of SARS-CoV-2 pose a significant challenge to the development of effective antibody-based treatments as immune evasion has compromised most available immune therapeutics. Therefore, in the ‘arms race’ with the virus, there is a continuing need to identify new biologics for the pr...
Príomhchruthaitheoirí: | , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
The Royal Society
2024-06-01
|
Sraith: | Open Biology |
Ábhair: | |
Rochtain ar líne: | https://royalsocietypublishing.org/doi/10.1098/rsob.230252 |